First Light Asset Management’s Aratana Therapeutics PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-410,176
Closed -$2.94M – 57
2016
Q4
$2.94M Sell
410,176
-57,567
-12% -$465K 1.29% 27
2016
Q3
$4.38M Sell
467,743
-217,178
-32% -$1.8M 1.89% 22
2016
Q2
$4.33M Buy
684,921
+236,915
+53% +$1.52M 2.01% 20
2016
Q1
$2.47M Buy
448,006
+52,963
+13% +$199K 1.25% 30
2015
Q4
$2.2M Buy
395,043
+312,132
+376% +$2.06M 0.92% 38
2015
Q3
$701K Buy
82,911
+12,291
+17% +$208K 0.35% 38
2015
Q2
$1.07M Buy
70,620
+6,414
+10% +$92.6K 0.5% 38
2015
Q1
$1.03M Buy
64,206
+6,141
+11% +$109K 0.53% 38
2014
Q4
$1.04M Buy
58,065
+4,398
+8% +$54.8K 0.59% 41
2014
Q3
$539K Buy
53,667
+1,433
+3% +$17.4K 0.37% 41
2014
Q2
$815K Buy
52,234
+2,971
+6% +$42.1K 0.55% 41
2014
Q1
$914K Sell
49,263
-5,026
-9% -$101K 0.65% 42
2013
Q4
$1.04M Buy
+54,289
New +$1.1M 0.88% 33

Other funds holding PETX

First Light Asset Management's PETX Position: Q1 2017 in Review

First Light Asset Management sold out of Aratana Therapeutics (PETX) in Q1 2017, closing a stake of 410,176 shares — an estimated $2.94M sold.

First Light Asset Management first reported a position in PETX in Q4 2013 and held it in 13 quarters. The position peaked at $4.38M in Q3 2016. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

  • First Light Asset Management reported no remaining Aratana Therapeutics position as of Q1 2017 after selling out during the quarter.
  • First Light Asset Management sold 410,176 Aratana Therapeutics shares in Q1 2017, an estimated $2.94M.
  • First Light Asset Management first reported a position in Aratana Therapeutics in Q4 2013 and held it in 13 quarters.
  • First Light Asset Management's Aratana Therapeutics position peaked at $4.38M in Q3 2016.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics as of Q1 2017.

Based on First Light Asset Management's 13F filing for Q1 2017, filed 15 May 2017.